On May 21 during the 90th National Pharmaceutical Trade Fair (Guangzhou), Qidu Pharma hosted a client appreciation event themed "United Journey: Forging an  Industrial-Commercial Community of Shared Future." Senior Vice President Cui Liangfeng and Assistant General Manager Zheng Xiangnan led the marketing team, with Marketing Director Zhai Yuguo chairing the gathering. Over 200 key clients nationwide attended to discuss collaborative development and future strategies.

Cui Liangfeng presented the company's production and operation, development performance and strategic vision. He shared key 2024 metrics including revenue growth, profitability, and market expansion, highlighting:

Progress on the intelligent oral solid dosage facility (annual capacity: 10 billion tablets/capsules)

Dedicated production lines for antibiotics, oncology, and hormonal therapies

He noted that since 2024, the company has received approval for over ten key products. Over the next two years, the company plans to receive approvals for 47 additional products in various therapeutic areas, including nephrology and urology drugs, parenteral nutrition drugs, drugs for regulating water, electrolyte, and acid-base balance, digestive system drugs, nutritional supplements, cardiovascular and neurological drugs, immunosuppressants, and anti-infective drugs, thus providing more market opportunities for its partners.

He conveyed several key points from Chairman Zheng Jiaqing regarding how to establish and maintain long-term strategic partnerships between industrial and commercial enterprises and their partners. First, always adhere to the business philosophy of 'integrity, cooperation, and development.' Second, consistently uphold the corporate mission of 'customer-centric and market-oriented.' Third, actively build a community of shared interests and destiny for industrial and commercial enterprises. Fourth, Qidu Pharma will always be a strong support for its customers.

Cui Liangfeng stated that, in the face of intense competition in the pharmaceutical industry, Qidu Pharma has strengthened its strategic partnership with customers through customer appreciation events, deepening the concept of a 'community of shared destiny between industry and commerce.' Qidu Pharma is committed to mutual trust, reliance, and win-win cooperation with its customers, embracing unity and shared destiny, 'sailing together, reaching far together,' to jointly promote the high-quality development of the pharmaceutical industry.